PO
Poly Medicure Limited
POLYMED.NS · NSE
₹1,617.90 +0.18% (+₹2.90)
1M -5.57%
Market Cap ₹162.1B
P/E Ratio 51.45x
Div. Yield 0.22%
ROE 10.41%
Bulios Fair Price
₹1,044
35.5% downside
Current Price
₹1,618
Undervalued Fair Value Overvalued
According to Bulios Fair Price, POLYMED.NS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
6 /100
Expensive P/E 51.45x
EV/EBITDA 30.29x
P/B 5.15x
Growth
97 /100
Growing EPS growth 19.36%
Rev. growth 18.91%
Book val. growth 35.75%
Profitability
57 /100
Moderate Gross margin 45.89%
Net margin 15.77%
FCF margin 3.30%
Quality
47 /100
Average ROE 10.41%
ROIC N/A
ROA N/A
Debt
100 /100
Low Debt/Equity 0.00x
Int. coverage 18.64x
Net debt/EBITDA 0.00x
Stability
67 /100
Stable Beta 0.01x
Rev. volatility 5.90%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about POLYMED.NS
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Himanshu Baid
Employees
2,614
Headquarters
New Delhi
Upcoming events
02 NOV
Earnings
Upcoming earnings report